| 摘要 |
<p>The present invention relates to a pharmaceutical composition including silkworm hemolymph as an active ingredient for prevention and treatment of tissue injury due to radiation. Specifically, the present invention confirms that the silkworm hemolymph can be usefully used as a composition for prevention and treatment of diseases due to radiation exposure such as tissue injury due to radiation since AST of plasma and liver tissues shows statistical significance, ALP of liver tissues increases, and the MDA content decreases, thereby alleviating the liver damage when the silkworm hemolymph is injected to animal models having liver damaged due to radiation.</p> |
